A previous study demonstrated that power against the (unobserved) true effect for the primary end point (PEP) of most phase III oncology trials is low, suggesting an increased risk of false-negative ...
OR: Odds ratio, 95% CI: 95% Confidence interval, HIV: Human Immunodeficiency virus This is an ASCO Meeting Abstract from the 2022 ASCO Annual Meeting I. This abstract does not include a full text ...
MANOVA is a statistical test that extends the scope of the more commonly used ANOVA, that allows differences between three or more independent groups of explanatory (independent or predictor) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results